China's National Medical Products Administration has granted marketing approval to Neuracle Medical Technology for the world's first commercially authorized brain-computer interface implant. The device is designed for adults aged 18-60 with spinal cord injuries who retain some upper arm function, helping them regain hand movement through a coin-sized wireless sensor placed on the brain's outer membrane.
The system detects brain signals linked to hand movement intentions, translates them via software, and sends commands to an air-powered robotic glove that assists patients in grasping objects. Clinical trials involving 36 patients demonstrated improved ability to hold and grab items. The approval covers the full system including implanted sensors, the robotic glove, surgical tools, and signal decoding software.
The approval puts China ahead of Elon Musk's Neuralink, which began human trials in 2024 with 12 recipients but has not yet received commercial clearance. China has elevated brain-computer interface technology to a national strategic priority, including it in this year's government work report as one of the country's "industries of the future."
